ABSTRACT. We have developed an in vivo medium-term liver initiation assay system to detect initiation activities of chemicals on multiorgan carcinogenesis. However, cell proliferation stimuli during the test chemical treatment period, required in the previously used assay models using adult rats, are laborious; moreover, those cause decrease of hepatic metabolic enzymes and psychological and physical discomfort to animals resulting in inaccurate interpretation. Therefore, we investigated the utility of another in vivo medium-term liver initiation assay model using 4-week-old rats without the cell proliferation stimuli. In this study, we confirmed that 4-week-old and 4.5-week-old male rats have high hepatocyte proliferation activity and similar enzyme activities of hepatic Cytochrome P450 subtypes as compared with 8-week-old male rats. Next, the in vivo medium-term liver initiation assay model using 4-week-old rats without cell proliferation stimuli was evaluated for the detection of the initiation activity of 1,2-dimethylhydrazine (DMH), which is a well-known genotoxic carcinogen. Four-week-old rats were orally administered DMH (single dose, 4 or 16 mg/kg; or 4-day repeat, 1 or 4 mg/kg); subsequently, these rats were treated promotion treatment consisted of administration of 2-acetylaminofluorene and carbon tetrachloride. Four weeks after the first DMH administration, the glutathione S-transferase placental form (GST-P)-positive foci induced by DMH in the liver was measured immunohistochemically. The inductions of GST-P-positive foci in all DMH-treated groups were dose-dependent, duration-dependent and significantly higher than that in non-DMH-treated group. From these results, our assay model was detected the initiation activity of DMH simply, and would be useful to evaluate the carcinogenicity of chemicals.KEY WORDS: 1,2-dimethylhydrazine (DMH)Introduction, carcinogenesis, GST-P-positive cell foci, liver, rat.J. Vet. Med. Sci. 72(1): 43-53, 2010 Several models are available today for studying the mechanism and activity of carcinogenesis in vivo, most comprising multistage studies involving initiation, promotion, and progression [15]. In vivo medium-term carcinogenic assays based on the multi-stage carcinogenesis hypothesis have been developed in order to bridge the gap between long-term in vivo carcinogenicity studies and shortterm in vitro screening tests [16,22,47,53]. The Ito model for the detection of the promotion activity in the liver has already been validated using a long list of chemicals and is widely used to detect the promotion activities of chemicals [23,24]. Initiation is also a key event in multi-stage carcinogenesis, resulting from complicated processes in vivo [17]. Therefore, an in vivo medium-term liver initiation assay model has also been developed to detect initiation activity of chemicals, and 26 well-known chemicals have been evaluated [38].The medium-term liver initiation assay model could detect genotoxic carcinogens, regardless of the target organ, with reference to the induction o...